Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Precision Biosciences (DTIL) Income from Continuing Operations (2018 - 2025)

Historic Income from Continuing Operations for Precision Biosciences (DTIL) over the last 8 years, with Q3 2025 value amounting to -$20.0 million.

  • Precision Biosciences' Income from Continuing Operations fell 118.37% to -$20.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$86.0 million, marking a year-over-year decrease of 67631.56%. This contributed to the annual value of -$21.2 million for FY2024, which is 4466.82% up from last year.
  • Precision Biosciences' Income from Continuing Operations amounted to -$20.0 million in Q3 2025, which was down 118.37% from -$21.1 million recorded in Q2 2025.
  • Precision Biosciences' Income from Continuing Operations' 5-year high stood at $25.4 million during Q2 2024, with a 5-year trough of -$30.7 million in Q4 2021.
  • Moreover, its 5-year median value for Income from Continuing Operations was -$13.9 million (2022), whereas its average is -$12.8 million.
  • Its Income from Continuing Operations has fluctuated over the past 5 years, first skyrocketed by 156480.41% in 2024, then tumbled by 58247.26% in 2025.
  • Over the past 5 years, Precision Biosciences' Income from Continuing Operations (Quarter) stood at -$30.7 million in 2021, then surged by 65.3% to -$10.7 million in 2022, then dropped by 28.0% to -$13.6 million in 2023, then crashed by 74.05% to -$23.7 million in 2024, then grew by 15.76% to -$20.0 million in 2025.
  • Its last three reported values are -$20.0 million in Q3 2025, -$21.1 million for Q2 2025, and -$21.1 million during Q1 2025.